217 related articles for article (PubMed ID: 27015456)
1. Excess Lymphangiogenesis Cooperatively Induced by Macrophages and CD4(+) T Cells Drives the Pathogenesis of Lymphedema.
Ogata F; Fujiu K; Matsumoto S; Nakayama Y; Shibata M; Oike Y; Koshima I; Watabe T; Nagai R; Manabe I
J Invest Dermatol; 2016 Mar; 136(3):706-714. PubMed ID: 27015456
[TBL] [Abstract][Full Text] [Related]
2. CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis.
Zampell JC; Yan A; Elhadad S; Avraham T; Weitman E; Mehrara BJ
PLoS One; 2012; 7(11):e49940. PubMed ID: 23185491
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Immunity by Lymphatic Dysfunction in Lymphedema.
Yuan Y; Arcucci V; Levy SM; Achen MG
Front Immunol; 2019; 10():76. PubMed ID: 30761143
[TBL] [Abstract][Full Text] [Related]
4. RAMP1 signaling improves lymphedema and promotes lymphangiogenesis in mice.
Mishima T; Ito Y; Nishizawa N; Amano H; Tsujikawa K; Miyaji K; Watanabe M; Majima M
J Surg Res; 2017 Nov; 219():50-60. PubMed ID: 29078910
[TBL] [Abstract][Full Text] [Related]
5. An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis.
Cheung L; Han J; Beilhack A; Joshi S; Wilburn P; Dua A; An A; Rockson SG
BioDrugs; 2006; 20(6):363-70. PubMed ID: 17176124
[TBL] [Abstract][Full Text] [Related]
6. Regulation of inflammation and fibrosis by macrophages in lymphedema.
Ghanta S; Cuzzone DA; Torrisi JS; Albano NJ; Joseph WJ; Savetsky IL; Gardenier JC; Chang D; Zampell JC; Mehrara BJ
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1065-77. PubMed ID: 25724493
[TBL] [Abstract][Full Text] [Related]
7. CD4
García Nores GD; Ly CL; Cuzzone DA; Kataru RP; Hespe GE; Torrisi JS; Huang JJ; Gardenier JC; Savetsky IL; Nitti MD; Yu JZ; Rehal S; Mehrara BJ
Nat Commun; 2018 May; 9(1):1970. PubMed ID: 29773802
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic endothelial cells, lymphedematous lymphangiogenesis, and molecular control of edema formation.
Ji RC
Lymphat Res Biol; 2008; 6(3-4):123-37. PubMed ID: 19093784
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury.
Zampell JC; Elhadad S; Avraham T; Weitman E; Aschen S; Yan A; Mehrara BJ
Am J Physiol Cell Physiol; 2012 Feb; 302(4):C709-19. PubMed ID: 22049214
[TBL] [Abstract][Full Text] [Related]
10. Adipose-derived stem cell transplantation for therapeutic lymphangiogenesis in a mouse secondary lymphedema model.
Yoshida S; Hamuy R; Hamada Y; Yoshimoto H; Hirano A; Akita S
Regen Med; 2015; 10(5):549-62. PubMed ID: 26237700
[TBL] [Abstract][Full Text] [Related]
11. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
Saito Y; Nakagami H; Morishita R; Takami Y; Kikuchi Y; Hayashi H; Nishikawa T; Tamai K; Azuma N; Sasajima T; Kaneda Y
Circulation; 2006 Sep; 114(11):1177-84. PubMed ID: 16952986
[TBL] [Abstract][Full Text] [Related]
12. Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.
Li J; Chen Y; Zhang L; Xing L; Xu H; Wang Y; Shi Q; Liang Q
J Ethnopharmacol; 2016 Dec; 193():293-302. PubMed ID: 27553977
[TBL] [Abstract][Full Text] [Related]
13. Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer.
Jeon BH; Jang C; Han J; Kataru RP; Piao L; Jung K; Cha HJ; Schwendener RA; Jang KY; Kim KS; Alitalo K; Koh GY
Cancer Res; 2008 Feb; 68(4):1100-9. PubMed ID: 18281485
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory and lymphangiogenetic effects of low-level laser therapy on lymphedema in an experimental mouse tail model.
Jang DH; Song DH; Chang EJ; Jeon JY
Lasers Med Sci; 2016 Feb; 31(2):289-96. PubMed ID: 26714983
[TBL] [Abstract][Full Text] [Related]
15. The resolution of lymphedema by interstitial flow in the mouse tail skin.
Uzarski J; Drelles MB; Gibbs SE; Ongstad EL; Goral JC; McKeown KK; Raehl AM; Roberts MA; Pytowski B; Smith MR; Goldman J
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1326-34. PubMed ID: 18203849
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal shock wave therapy combined with vascular endothelial growth factor-C hydrogel for lymphangiogenesis.
Kim IG; Lee JY; Lee DS; Kwon JY; Hwang JH
J Vasc Res; 2013; 50(2):124-33. PubMed ID: 23208012
[TBL] [Abstract][Full Text] [Related]
17. Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis.
Hos D; Regenfuss B; Bock F; Onderka J; Cursiefen C
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5778-85. PubMed ID: 21666240
[TBL] [Abstract][Full Text] [Related]
18. Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema.
Kashiwagi S; Hosono K; Suzuki T; Takeda A; Uchinuma E; Majima M
Lab Invest; 2011 Sep; 91(9):1314-25. PubMed ID: 21577211
[TBL] [Abstract][Full Text] [Related]
19. Endogenous Calcitonin Gene-Related Peptide Deficiency Exacerbates Postoperative Lymphedema by Suppressing Lymphatic Capillary Formation and M2 Macrophage Accumulation.
Matsui S; Tanaka M; Kamiyoshi A; Sakurai T; Ichikawa-Shindo Y; Kawate H; Dai K; Cui N; Wei Y; Tanaka M; Kakihara S; Nakamura K; Yamauchi A; Ishida K; Tanaka S; Kawamata M; Shindo T
Am J Pathol; 2019 Dec; 189(12):2487-2502. PubMed ID: 31541644
[TBL] [Abstract][Full Text] [Related]
20. Abnormal lymphatic S1P signaling aggravates lymphatic dysfunction and tissue inflammation.
Kim D; Tian W; Wu TT; Xiang M; Vinh R; Chang J; Gu S; Lee S; Zhu Y; Guan T; Schneider EC; Bao E; Dixon JB; Kao P; Pan J; Rockson SG; Jiang X; Nicolls MR
medRxiv; 2023 Jun; ():. PubMed ID: 37398237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
